皮下药物输送设备的全球市场:产业分析，规模，占有率，成长，趋势，预测(2022年～2028年)

全球皮下药物输送设备市场今后数年预计将显着成长。

本报告提供全球皮下药物输送设备市场调查，提供促进因素，阻碍因素，课题，市场机会，价值链分析，COVID-19影响，各产品·各流通管道·各地区的市场分析，竞争情形，企业简介等资讯。

目录

第1章 序文

第2章 摘要整理

第3章 皮下药物输送设备 - 产业分析

• 简介 - 市场动态
• 推动市场要素
• 阻碍市场要素
• 市场机会
• 产业趋势
• 波特的五力分析
• 市场魅力分析

第4章 价值链分析

• 价值链分析
• 原料分析
• 潜在的买主清单
• 行销流通管道

第5章 COVID-19发生的影响分析

• COVID-19发生的影响分析
• COVID-19影响分析:生产，进口，出口·各需求
• 市场:COVID-19以前 vs COVID-19以后
• COVID-19:影响估计
• COVID-19:微观及宏观因素分析

第6章 全球皮下药物输送设备市场分析:各产品

• 概要:各产品
• 实际成果资料与预测资料
• 分析:各产品
• 预填充式注射器市场:各地区
• 笔注射器市场:各地区
• 自动注射器市场:各地区
• 穿戴式注射器市场:各地区
• 无针注射器市场:各地区

第7章 全球皮下药物输送设备市场分析:各流通管道

• 概要:各流通管道
• 实际成果资料与预测资料
• 分析:各流通管道
• 医院药局市场:各地区
• 零售药局市场:各地区
• 线上药局市场:各地区

第8章 全球皮下药物输送设备市场分析:各地区

• 地区预测
• 简介
• 北美
• 欧洲
• 亚太地区
• 南美
• 中东·非洲

第9章 皮下药物输送设备企业的竞争情形

• 皮下药物输送设备市场竞争
• 伙伴关係/合作/契约
• 合併·收购
• 新产品的销售
• 其他的开发

第10章 企业简介

• 企业占有率分析
• 市场集中度
• Gerresheimer AG
• Becton
• Ypsomed AG
• Novo Nordisk
• Dickinson and Company
• Elcam Medical Group
• Medtronic Plc
• Insulet Corporation
• West Pharmaceutical Services, Inc.
• Inolife Sciences
• PharmaJet
• Unilife Corporation

附註:财务细节和公司概况的最新发展需该公司予以公开。可能不包含私人公司在内。

Value Market Research deeply researched the Global Subcutaneous Drug Delivery Devices Market to foresee a significant growth in the industry over the upcoming years. The global subcutaneous drug delivery devices market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global subcutaneous drug delivery devices market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this subcutaneous drug delivery devices market.

The next sections of the subcutaneous drug delivery devices market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Product

Prefilled syringes

Pen injectors

Auto-injectors

Wearable injectors

Needle-free Injectors

By Distribution Channel

Hospital pharmacies

Retail pharmacies

Online pharmacies

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . SUBCUTANEOUS DRUG DELIVERY DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Product
  • 3.7.2 By Distribution Channel
  • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Prefilled syringes Market by Regions
• 6.6 Pen injectors Market by Regions
• 6.5 Auto-injectors Market by Regions
• 6.7 Wearable injectors Market by Regions
• 6.8 Needle-free Injectors Market by Regions

7 . GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 7.1 Overview by Distribution Channel
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Distribution Channel
• 7.4 Hospital pharmacies Market by Regions
• 7.5 Retail pharmacies Market by Regions
• 7.6 Online pharmacies Market by Regions

8 . GLOBAL SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America
  • 8.3.1. Overview, Historic and Forecast Data
  • 8.3.2. North America By Segment
  • 8.3.3. North America By Country
  • 8.3.4. United State
  • 8.3.5. Canada
  • 8.3.6. Mexico
• 8.4. Europe
  • 8.4.1. Overview, Historic and Forecast Data
  • 8.4.2. Europe by Segment
  • 8.4.3. Europe by Country
  • 8.4.4. United Kingdom
  • 8.4.5. France
  • 8.4.6. Germany
  • 8.4.7. Italy
  • 8.4.8. Russia
  • 8.4.9. Rest Of Europe
• 8.5. Asia Pacific
  • 8.5.1. Overview, Historic and Forecast Data
  • 8.5.2. Asia Pacific by Segment
  • 8.5.3. Asia Pacific by Country
  • 8.5.4. China
  • 8.5.5. India
  • 8.5.6. Japan
  • 8.5.7. South Korea
  • 8.5.8. Australia
  • 8.5.9. Rest Of Asia Pacific
• 8.6. Latin America
  • 8.6.1. Overview, Historic and Forecast Data
  • 8.6.2. Latin America by Segment
  • 8.6.3. Latin America by Country
  • 8.6.4. Brazil
  • 8.6.5. Argentina
  • 8.6.6. Peru
  • 8.6.7. Chile
  • 8.6.8. Rest of Latin America
• 8.7. Middle East & Africa
  • 8.7.1. Overview, Historic and Forecast Data
  • 8.7.2. Middle East & Africa by Segment
  • 8.7.3. Middle East & Africa by Country
  • 8.7.4. Saudi Arabia
  • 8.7.5. UAE
  • 8.7.6. Israel
  • 8.7.7. South Africa
  • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE SUBCUTANEOUS DRUG DELIVERY DEVICES COMPANIES

• 9.1. Subcutaneous Drug Delivery Devices Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF SUBCUTANEOUS DRUG DELIVERY DEVICES INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Gerresheimer AG
  • 10.3.1. Company Overview
  • 10.3.2. Financials
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Becton
  • 10.4.1. Company Overview
  • 10.4.2. Financials
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Ypsomed AG
  • 10.5.1. Company Overview
  • 10.5.2. Financials
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Becton
  • 10.6.1. Company Overview
  • 10.6.2. Financials
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Novo Nordisk
  • 10.7.1. Company Overview
  • 10.7.2. Financials
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Dickinson and Company
  • 10.8.1. Company Overview
  • 10.8.2. Financials
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Elcam Medical Group
  • 10.9.1. Company Overview
  • 10.9.2. Financials
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Medtronic Plc
  • 10.10.1. Company Overview
  • 10.10.2. Financials
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Insulet Corporation
  • 10.11.1. Company Overview
  • 10.11.2. Financials
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Becton
  • 10.12.1. Company Overview
  • 10.12.2. Financials
  • 10.12.3. Products
  • 10.12.4. Recent Developments
• 10.13. West Pharmaceutical Services, Inc.
  • 10.13.1. Company Overview
  • 10.13.2. Financials
  • 10.13.3. Products
  • 10.13.4. Recent Developments
• 10.14. Inolife Sciences
  • 10.14.1. Company Overview
  • 10.14.2. Financials
  • 10.14.3. Products
  • 10.14.4. Recent Developments
• 10.15. PharmaJet
  • 10.15.1. Company Overview
  • 10.15.2. Financials
  • 10.15.3. Products
  • 10.15.4. Recent Developments
• 10.16. Unilife Corporation
  • 10.16.1. Company Overview
  • 10.16.2. Financials
  • 10.16.3. Products
  • 10.16.4. Recent Developments
• 10.17. 0
  • 10.17.1. Company Overview
  • 10.17.2. Financials
  • 10.17.3. Products
  • 10.17.4. Recent Developments
• 10.18. 0
  • 10.18.1. Company Overview
  • 10.18.2. Financials
  • 10.18.3. Products
  • 10.18.4. Recent Developments
• 10.19. COMPANY H
  • 10.19.1. Company Overview
  • 10.19.2. Financials
  • 10.19.3. Products
  • 10.19.4. Recent Developments
• 10.20. COMPANY I
  • 10.20.1. Company Overview
  • 10.20.2. Financials
  • 10.20.3. Products
  • 10.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Product (USD MN)
• Prefilled syringes Market by Geography (USD MN)
• Pen injectors Market by Geography (USD MN)
• Auto-injectors Market by Geography (USD MN)
• Wearable injectors Market by Geography (USD MN)
• Needle-free Injectors Market by Geography (USD MN)
• Analysis Market by Distribution Channel (USD MN)
• Hospital pharmacies Market by Geography (USD MN)
• Retail pharmacies Market by Geography (USD MN)
• Online pharmacies Market by Geography (USD MN)
• Global Subcutaneous Drug Delivery Devices Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Subcutaneous Drug Delivery Devices Report
• Market Research Process
• Market Research Methodology
• Global Subcutaneous Drug Delivery Devices Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Prefilled syringes Market by Geography (USD MN)
• Pen injectors Market by Geography (USD MN)
• Auto-injectors Market by Geography (USD MN)
• Wearable injectors Market by Geography (USD MN)
• Needle-free Injectors Market by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Hospital pharmacies Market by Geography (USD MN)
• Retail pharmacies Market by Geography (USD MN)
• Online pharmacies Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.